Article Versions Notes

Lin C-L, Wu S-Y, Lai M-W, Hsu C-W, Chen W-M, Jao A-T, Chien C-H, Hu C-C, Chien R-N, Yeh C-T. Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy. Cancers. 2023; 15(13):3343. https://doi.org/10.3390/cancers15133343

Lin, Chih-Lang, Szu-Yuan Wu, Ming-Wei Lai, Chao-Wei Hsu, Wan-Ming Chen, An-Tzu Jao, Cheng-Hung Chien, Ching-Chih Hu, Rong-Nan Chien, and Chau-Ting Yeh. 2023. "Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy" Cancers 15, no. 13: 3343. https://doi.org/10.3390/cancers15133343

Lin, C.-L., Wu, S.-Y., Lai, M.-W., Hsu, C.-W., Chen, W.-M., Jao, A.-T., Chien, C.-H., Hu, C.-C., Chien, R.-N., & Yeh, C.-T. (2023). Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy. Cancers, 15(13), 3343. https://doi.org/10.3390/cancers15133343